| Website | xanodyne.com |
| Category | BioTech |
| Employees | |
| Description | Pharmaceutical Company |
| TOTAL | $38M |
| FUNDING TOTAL | $38M |
| Series D, 6/09 MPM Capital AIG Investments Aisling Capital Blue Chip Venture Company Essex Woodlands Health Ventures HealthCare Ventures Union Spring Pharmaceuticals | $38M |
Xanodyne Pharmaceuticals, founded in 2001, is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management. The company markets a portfolio of revenue generating products consisting of prescription pharmaceuticals and a line of prenatal vitamins, and we are advancing a late stage pipeline of product candidates targeted at significant potential markets in Xanodyne’s focus areas.
